Long-term safety of ustekinumab in Crohn’s disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data

Authors

Laurent Beaugerie (ORCID: https://orcid.org/0000-0002-5012-4146)
Laurent Peyrin‐Biroulet (ORCID: https://orcid.org/0000-0003-2536-6618)
Charlotte Mailhat
Anja Geldhof (ORCID: https://orcid.org/0000-0002-6476-5526)
Hélène Rousseau
Ahlem Azzabi
Filip Baert
Maciej Nazar
Jean-François Rahier
Anna Sheahan

Institutions

Inserm (FR)
Warsaw University of Life Sciences (PL)
Johnson City Medical Center (US)
Sorbonne Université (FR)
Centre Hospitalier Régional et Universitaire de Nancy (FR)
Springhouse (US)
Groupe d'Étude Thérapeutique des Affections Inflammatoires du Tube Digestif (FR)
Centre d’Investigation Clinique Innovation Technologique de Nancy (FR)
Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
AZ Delta (BE)
Janssen (Netherlands) (NL)
UCLouvain (BE)

Publication Details

Journal: Digestive and Liver Disease
Published: 2025-10-25
DOI: https://doi.org/10.1016/j.dld.2025.09.026
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Long-term safety of ustekinumab in Crohn’s disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data

Laurent Beaugerie, Laurent Peyrin‐Biroulet, Charlotte Mailhat, Anja Geldhof et al.

Oct 25, 2025

Digestive and Liver Disease

Inflammatory Bowel Disease

article

Long-term safety of ustekinumab in Crohn’s disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data

Laurent Beaugerie, Laurent Peyrin‐Biroulet, Charlotte Mailhat, Anja Geldhof, Hélène Rousseau, Ahlem Azzabi, Filip Baert, Maciej Nazar, Jean-François Rahier, Anna Sheahan

October 25, 2025article en

Abstract

No abstract available for this paper.

Digestive and Liver DiseaseVol. 58(1)

Inserm (FR), Warsaw University of Life Sciences (PL), Johnson City Medical Center (US), Sorbonne Université (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Springhouse (US), Groupe d'Étude Thérapeutique des Affections Inflammatoires du Tube Digestif (FR), Centre d’Investigation Clinique Innovation Technologique de Nancy (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), AZ Delta (BE), Janssen (Netherlands) (NL), UCLouvain (BE)

Openalex Percentile: Top 67%

Inflammatory Bowel Disease

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.